AAAAAA
Results: 1-25/27
Authors:
Hopf, U
Citation: U. Hopf, Indications for liver biopsy in the case of a hepatic tumor, DEUT MED WO, 126(16), 2001, pp. 480-480
Authors:
Seehofer, D
Rayes, N
Steinmuller, T
Muller, AR
Settmacher, U
Neuhaus, R
Radke, C
Berg, T
Hopf, U
Neuhaus, P
Citation: D. Seehofer et al., Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation, LIVER TRANS, 7(11), 2001, pp. 976-982
Authors:
Teuber, G
Berg, T
Naumann, U
Raedle, J
Brinkmann, S
Hopf, U
Zeuzem, S
Citation: G. Teuber et al., Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C, J VIRAL HEP, 8(4), 2001, pp. 276-283
Authors:
Barth, H
Klein, R
Berg, PA
Wiedenmann, B
Hopf, U
Berg, T
Citation: H. Barth et al., Induction of T helper cell type 1 response and elimination of HBeAg duringtreatment with IL-12 in a patient with therapy-refractory chronic hepatitis B, HEP-GASTRO, 48(38), 2001, pp. 553-555
Authors:
Berg, T
Naumann, U
Wiedenmann, B
Hopf, U
Citation: T. Berg et al., Pilot study of interferon-alpha high-dose induction therapy in combinationwith ribavirin plus amantadine for nonresponder patients with chronic hepatitis C, Z GASTROENT, 39(2), 2001, pp. 145
Authors:
Mueller, AR
Platz, KP
Willimski, C
Berg, T
Steinmuller, T
Neumann, U
Neuhaus, R
Hopf, U
Radke, C
Neuhaus, P
Citation: Ar. Mueller et al., Influence of immunosuppression on patient survival after liver transplantation for hepatitis C, TRANSPLAN P, 33(1-2), 2001, pp. 1347-1349
Authors:
Rayes, N
Seehofer, D
Hopf, U
Neuhaus, R
Naumann, U
Bechstein, WO
Neuhaus, P
Citation: N. Rayes et al., Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation, TRANSPLANT, 71(1), 2001, pp. 96-101
Authors:
Berg, T
Hopf, U
Schuff-Werner, P
Citation: T. Berg et al., Sustained remission of chronic hepatitis C after a change to human leukocyte interferon-alpha in a difficult-to-treat patient with breakthrough phenomenon associated with antibodies against recombinant interferon-alpha, AM J GASTRO, 96(2), 2001, pp. 612-614
Authors:
Seehofer, D
Rayes, N
Berg, T
Neuhaus, R
Muller, AR
Hopf, U
Bechstein, WO
Neuhaus, P
Citation: D. Seehofer et al., Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation, TRANSPLAN I, 13(4), 2000, pp. 290-296
Authors:
Berg, T
Marques, AM
Hohne, M
Wiedenmann, B
Hopf, U
Schreier, E
Citation: T. Berg et al., Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment, HEPATOLOGY, 32(6), 2000, pp. 1386-1395
Authors:
Zeuzem, S
Teuber, G
Naumann, U
Berg, T
Raedle, J
Hartmann, S
Hopf, U
Citation: S. Zeuzem et al., Randomized, double-blind, placebo-controlled trial of interferon Alfa2a with and without amantadine as initial treatment for chronic hepatitis C, HEPATOLOGY, 32(4), 2000, pp. 835-841
Authors:
Carreno, V
Zeuzem, S
Hopf, U
Marcellin, P
Cooksley, WGE
Fevery, J
Diago, M
Reddy, R
Peters, M
Rittweger, K
Rakhit, A
Pardo, M
Citation: V. Carreno et al., A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B, J HEPATOL, 32(2), 2000, pp. 317-324
Authors:
Berg, T
Hoffmann, RM
Teuber, G
Leifeld, L
Lafrenz, M
Baumgarten, R
Spengler, U
Zeuzem, S
Pape, GR
Hopf, U
Citation: T. Berg et al., Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients withchronic hepatitis C: a randomized multicenter trial, LIVER, 20(6), 2000, pp. 427-436
Authors:
Seehofer, D
Rayes, N
Bechstein, WO
Naumann, U
Neuhaus, R
Berg, T
Hopf, U
Langrehr, JM
Steinmuller, T
Platz, KP
Muller, AR
Neuhaus, P
Citation: D. Seehofer et al., Antiviral therapy of recurrent hepatitis B infection after liver transplantation: A retrospective analysis of 200 liver transplants for hepatitis B related fiver diseases, Z GASTROENT, 38(9), 2000, pp. 773
Authors:
Berg, T
Kaul, T
Naumann, U
Wiedenmann, B
Hopf, U
Citation: T. Berg et al., Influence of ribavirin on the dynamics of hepatitis C viremia in interferon-alpha-treated patients with response or nonresponse, Z GASTROENT, 38(11), 2000, pp. 881-886
Authors:
Seehofer, D
Rayes, N
Berg, T
Neuhaus, R
Hopf, U
Muller, AR
Bechstein, WO
Neuhaus, P
Citation: D. Seehofer et al., Additional interferon alpha for lamivudine resistant hepatitis B infectionafter liver transplantation: A preliminary report, TRANSPLANT, 69(8), 2000, pp. 1739-1742
Authors:
Teuber, G
Berg, T
Hoffmann, RM
Leifeld, L
Lafrenz, M
Spengler, U
Pape, GR
Hopf, U
Zeuzem, S
Citation: G. Teuber et al., Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C, DIGESTION, 61(2), 2000, pp. 90-97
Authors:
Zeuzem, S
Hopf, U
Carreno, V
Diago, M
Shiffman, M
Grune, S
Dudley, FJ
Rakhit, A
Rittweger, K
Yap, SH
Koff, RS
Thomas, HC
Citation: S. Zeuzem et al., A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C, HEPATOLOGY, 29(4), 1999, pp. 1280-1287
Authors:
Berg, T
Muller, AR
Platz, KP
Hohne, M
Bechstein, WO
Hopf, U
Wiedenmann, B
Neuhaus, P
Schreier, E
Citation: T. Berg et al., Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication, HEPATOLOGY, 29(1), 1999, pp. 245-249
Authors:
Berg, T
Schreier, E
Heuft, HG
Hohne, M
Bechstein, WO
Leder, K
Hopf, U
Neuhaus, P
Wiedenmann, B
Citation: T. Berg et al., Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donors, J MED VIROL, 59(1), 1999, pp. 117-121
Authors:
Hoffmann, RM
Berg, T
Teuber, G
Prummer, O
Leifeld, L
Jung, MC
Spengler, U
Zeuzem, S
Hopf, U
Pape, GR
Citation: Rm. Hoffmann et al., Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C, Z GASTROENT, 37(8), 1999, pp. 715-723
Authors:
Gotz, G
Neuhaus, R
Bechstein, WO
Lobeck, H
Berg, T
Hopf, U
Neuhaus, P
Citation: G. Gotz et al., Recurrence of autoimmune hepatitis after liver transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 430-431
Authors:
Rayes, N
Neuhaus, R
Naumann, U
Hopf, U
Haller, GW
Bechstein, WO
Neuhaus, P
Citation: N. Rayes et al., Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir - How effective is it?, TRANSPLAN P, 31(1-2), 1999, pp. 481-482
Authors:
Klein, R
Zanger, UM
Berg, T
Hopf, U
Berg, PA
Citation: R. Klein et al., Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and navel peptide epitopes, CLIN EXP IM, 118(2), 1999, pp. 290-297
Authors:
Grote, M
Reichart, PA
Berg, T
Hopf, U
Citation: M. Grote et al., Hepatitis C virus (HCV)-infection and oral lichen planus, J HEPATOL, 29(6), 1998, pp. 1034-1035